C91.52
Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse
Clinical Classification Guidelines
Medical Intelligence & Overview
Adult T-cell lymphoma/leukemia (ATLL) associated with the human T-cell lymphotropic virus type 1 (HTLV-1) is a rare but serious type of cancer affecting the lymphatic system. When the disease returns after treatment, it is referred to as in relapse. This condition involves the abnormal growth of T-cells, a type of white blood cell vital for immune function. Understanding the nature of this disease, its causes, symptoms, and available management options can help in appreciating its impact and the importance of ongoing medical care.
Causes & Symptoms
Clinical Causes: Primary cause of ATLL associated with HTLV-1 infection, which is a virus transmitted through blood, sexual contact, or from mother to child during breastfeeding. Long-term carrier status of HTLV-1 can lead to the malignant transformation of T-cells, resulting in lymphoma or leukemia. In some cases, genetic factors may influence susceptibility, but the strongest link remains with HTLV-1 infection.
Key Symptoms: Persistent fever and night sweats. Unintentional weight loss. Swollen lymph nodes, especially in the neck, armpits, or groin. Fatigue and weakness. Skin lesions or rashes. Enlargement of the spleen or liver. Persistent infections due to immune suppression.
Diagnostic & Treatment
Diagnosis Path: Blood tests to assess abnormal lymphocytes and HTLV-1 antibodies. Lymph node biopsy or affected tissue examination under a microscope. Flow cytometry to analyze cell surface markers. Imaging tests such as CT scans or PET scans to determine the extent of disease spread. Molecular studies to detect HTLV-1 integration in T-cells.
Treatment Protocols: Chemotherapy regimens tailored to target rapidly dividing cancer cells. Targeted therapies aiming at specific molecular features of the lymphoma/leukemia. Stem cell or bone marrow transplantation may be considered for suitable candidates. Supportive care to manage symptoms, prevent infections, and maintain quality of life. Participation in clinical trials exploring new treatments may be an option for some patients.
Clinical Advice & FAQs
Billing Guidance
Is C91.52 a billable ICD-10 code?
Yes, C91.52 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C91.52?
Clinical documentation must specify the nature of Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse and any associated comorbidities for accurate reporting.
Cite this Clinical Reference